資源描述:
《抗癲癇藥物血藥濃度監(jiān)測(cè)結(jié)果探討》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫。
1、抗癲癇藥物血藥濃度監(jiān)測(cè)結(jié)果探討幸勇宣漢縣人民醫(yī)院四川達(dá)州636150【摘要】目的:探討抗癲癇藥物血藥濃度監(jiān)測(cè)特點(diǎn)。方法:選取中請(qǐng)監(jiān)測(cè)抗癲癇藥物血藥濃度的癲癇患者100例次,均為我院2012年1月至2014年10月收治,回顧血藥濃度監(jiān)測(cè)結(jié)果計(jì)算血藥濃度與不良反應(yīng)的Eta系數(shù),分析血藥濃度與藥物治療效果的關(guān)系。結(jié)果:抗癲癇藥患者100例次中,PT13例次,CB31例次;PB13例次,VPA43例次;聯(lián)合用藥20例次。依據(jù)監(jiān)測(cè)的血藥濃度結(jié)果,按A組低于有效濃度、B組在有效范圍內(nèi)、C組高于有效濃度劃分,其中A組40例次,B組56例次,C組4例次。C組VPA、PT、PB、CBZ均高于A組、B組,有統(tǒng)計(jì)學(xué)
2、差異(P<0.05)聯(lián)用藥20例次,其中PT與其他藥物聯(lián)用5例。20例次中,監(jiān)測(cè)結(jié)果不在藥物治療濃度范圍16例,占80%。聯(lián)用藥平均血藥濃度(20.1±12.8)μg/ml,明顯高于單用藥組(11.0±8.2)μg/mloA組血藥濃度與不良反應(yīng)的Eta系數(shù)為0.558,B組為0.977,C組為0.968。A組40例次,總有效率為70%;B組56例次,總有效率為96.4%,C組4例次,總有效率為50%。木次100例患者中,用藥治療后,A組癲癇再發(fā)4次,B組0例,C組3次。結(jié)論:針對(duì)癲癇患者應(yīng)用抗癲癇藥物行血藥濃度監(jiān)測(cè),可指導(dǎo)臨床用藥,防范不良反應(yīng),提
3、高臨床沿療總有效率?!娟P(guān)鍵詞】抗癲癇藥物;監(jiān)測(cè);血藥濃度【中圖分類號(hào)】R742.1【文獻(xiàn)標(biāo)識(shí)碼】A【文章編號(hào)】1276-7808(2015)-06-015-02[Abstract]Objective:Toinvestigatetheantiepilepticdrugbloodconcentrationmonitoringfeatures.Methods:atotalof100casesofapplicationmonitoringantiepilepticdrugs;blooddrugconcentrationinpatientswithepilepsywerefromourhospitali
4、nJanuary2012to2014October.ReviewofblooddrugconcentrationmonitoringresultsplasmaconcentrationandadversereactionofETAcoefficient,analysistherelationshipbetweenblooddrugconcentrationanddrugtreatmentefficacy.Results:100casesofpatientswithPT13cases,antiepilepticdrugs,CB31cases;PB13cases,VPA43cases;20case
5、sofdrugcombination.Accordingtothemonitoringofblooddrugconcentrationresults,ingroupAwaslowerthanthatofeffectiveconcentration,Bgroupwithintheeffectiverange,Cgroupishigherthantheeffectiveconcentrationofdivision,ofwhichagroupof40cases,Bgroup(n=56),groupC(n=4).CtheVPAgroup,Pt,Pb,CBZweresignificantlyhighe
6、rthanthoseingroupA,groupB,therearestatisticaldifferences(P<0.05)combinationtherapyin20cases,whichPtandotherdrugscombinedwith5cases.Amongthe20cases,themonitoringresultsindrugconcentrationrangeof16cases,accountingfor80%.Theaveragedrugbloodconcentration(20.1+12.8)g/ml,significantlyhigherthanthesingl
7、edruggroup(11+8.2)g/ml.TheEtacoefficientofgroupAblooddrugconcentrationandadversereactionswas0.558,0.977inBgroup,Cgroupwas0.968.Agroupof40cases,thetotaleffectiveratewas70%;Bgroupof56cases,thetotaleffec